Gene · 3482
Papers4,462
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 4,462
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Synergistic effects of hormones on structural and functional maturation of cardiomyocytes and implications for heart regeneration. | Cell Mol Life Sci | 2023 | 37541969 | PubTator, text mining | PubMed |
| Biomarkers of obesity-mediated insulin resistance: focus on microRNAs. | Diabetol Metab Syndr | 2023 | 37537674 | PubTator, text mining | PubMed |
| Population pharmacokinetic modeling and dosing simulation of avalglucosidase alfa for selecting alternative dosing regimen in pediatric patients with late-onset pompe disease. | J Pharmacokinet Pharmacodyn | 2023 | 37535240 | PubTator, text mining | PubMed |
| Case report: atypical Silver-Russell syndrome patient with hand dystonia: the valuable support of the consensus statement to the wide syndromic spectrum. | Front Genet | 2023 | 37529781 | PubTator, text mining | PubMed |
| Identification and Interaction Analysis of Molecular Markers in Pancreatic Ductal Adenocarcinoma by Bioinformatics and Next-Generation Sequencing Data Analysis. | Bioinform Biol Insights | 2023 | 37529485 | PubTator, text mining | PubMed |
| Proximity-Based Modalities for Biology and Medicine. | ACS Cent Sci | 2023 | 37521793 | PubTator, text mining | PubMed |
| Image-Based Dosimetry in Dogs and Cross-Reactivity with Human Tissues of IGF2R-Targeting Human Antibody. | Pharmaceuticals (Basel) | 2023 | 37513891 | PubTator, text mining | PubMed |
| The Molecular and Genetic Interactions between Obesity and Breast Cancer Risk. | Medicina (Kaunas) | 2023 | 37512149 | PubTator, text mining | PubMed |
| Repositioning of Anti-Diabetic Drugs against Dementia: Insight from Molecular Perspectives to Clinical Trials. | Int J Mol Sci | 2023 | 37511207 | PubTator, text mining | PubMed |
| The Role of SOX9 in IGF-II-Mediated Pulmonary Fibrosis. | Int J Mol Sci | 2023 | 37510994 | PubTator, text mining | PubMed |
| Circular RNA as a Novel Regulator and Promising Biomarker in Polycystic Ovary Syndrome. | Biomolecules | 2023 | 37509138 | PubTator, text mining | PubMed |
| Exposure to endocrine disrupting chemicals impacts immunological and metabolic status of women during pregnancy. | Mol Cell Endocrinol | 2023 | 37506868 | PubTator, text mining | PubMed |
| E3 ubiquitin ligases and deubiquitinases in bladder cancer tumorigenesis and implications for immunotherapies. | Front Immunol | 2023 | 37497216 | PubTator, text mining | PubMed |
| Large-Scale CRISPR Screen of LDLR Pathogenic Variants. | Research (Wash D C) | 2023 | 37496633 | PubTator, text mining | PubMed |
| Orchestration of Mesenchymal Stem/Stromal Cells and Inflammation During Wound Healing. | Stem Cells Transl Med | 2023 | 37487541 | PubTator, text mining | PubMed |
| Lysosomes, curcumin, and anti-tumor effects: how are they linked? | Front Pharmacol | 2023 | 37484013 | PubTator, text mining | PubMed |
| Beyond canonical PROTAC: biological targeted protein degradation (bioTPD). | Biomater Res | 2023 | 37480049 | PubTator, text mining | PubMed |
| Metronomic Administration of Topotecan Alone and in Combination with Docetaxel Inhibits Epithelial-mesenchymal Transition in Aggressive Variant Prostate Cancers. | Cancer Res Commun | 2023 | 37476073 | PubTator, text mining | PubMed |
| AAV-mediated delivery of secreted acid α-glucosidase with enhanced uptake corrects neuromuscular pathology in Pompe mice. | JCI Insight | 2023 | 37463048 | PubTator, text mining | PubMed |
| RAGE inhibition blunts insulin-induced oncogenic signals in breast cancer. | Breast Cancer Res | 2023 | 37461077 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3482/papers?page=17